1. Home
  2. ISSC vs PRLD Comparison

ISSC vs PRLD Comparison

Compare ISSC & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Solutions and Support Inc.

ISSC

Innovative Solutions and Support Inc.

HOLD

Current Price

$18.10

Market Cap

293.3M

Sector

Technology

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$4.73

Market Cap

346.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISSC
PRLD
Founded
1988
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.3M
346.5M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
ISSC
PRLD
Price
$18.10
$4.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$18.25
$5.67
AVG Volume (30 Days)
433.0K
489.1K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
23.21
EPS
0.41
N/A
Revenue
N/A
$12,140,000.00
Revenue This Year
$7.95
$320.10
Revenue Next Year
$6.82
$100.00
P/E Ratio
$43.63
N/A
Revenue Growth
N/A
73.43
52 Week Low
$8.13
$0.75
52 Week High
$30.98
$5.54

Technical Indicators

Market Signals
Indicator
ISSC
PRLD
Relative Strength Index (RSI) 52.35 60.83
Support Level $17.57 $3.92
Resistance Level $19.92 $5.43
Average True Range (ATR) 1.12 0.35
MACD 0.17 0.05
Stochastic Oscillator 59.63 92.78

Price Performance

Historical Comparison
ISSC
PRLD

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: